Myomo (MYO) Return on Capital Employed Growth (3y) (2020 - 2025)
Myomo (MYO) Return on Capital Employed Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | - |
| 10 | Myomo | 42.71 Mn | 23.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7,700.00 |
| Jun 30, 2025 | 5,049.00 |
| Mar 31, 2025 | 5,050.00 |
| Dec 31, 2024 | 3,836.00 |
| Sep 30, 2024 | -2,393.00 |
| Jun 30, 2024 | -3,500.00 |
| Mar 31, 2024 | -2,156.00 |
| Dec 31, 2023 | 674.00 |
| Sep 30, 2023 | 1,047.00 |
| Jun 30, 2023 | 385.00 |
| Mar 31, 2023 | 2,939.00 |
| Dec 31, 2022 | 29,797.00 |
| Sep 30, 2022 | 7,310.00 |
| Jun 30, 2022 | 4,545.00 |
| Mar 31, 2022 | 6,319.00 |
| Dec 31, 2021 | 6,588.00 |
| Sep 30, 2021 | 2,873.00 |
| Jun 30, 2021 | 600.00 |
| Mar 31, 2021 | -1,642.00 |
| Dec 31, 2020 | -914.00 |